Changes in the SHBG concentration during danazol treatment
Danazol treatment rapidly and proportionally decreased serum sex hormone binding globulin levels in a dose-dependent manner in both pre- and postmenopausal women, suggesting direct hepatic synthesis inhibition.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (24)
- A comparison of plasma protein changes induced by danazol, pregnancy, and estrogens via openalex
- Danazol and gestagen displacement of testosterone and influence on sex-hormone-binding globulin capacity via openalex
- Danazol--a synthetic steroid derivative with interesting physiologic properties via openalex
- Danazol binding and translocation of steroid receptors via openalex
- Danazol binding to rat androgen, glucocorticoid, progesterone, and estrogen receptors: correlation with biologic activity via openalex
- Danazol suppresses luteal function in vitro and in vivo via openalex
- Danazol suppression of luteinizing hormone secretion: a role for danazol-androgen receptor interaction within the brain-pituitary complex via openalex
- Evidence that danazol inhibits gonadotropin-induced ovarian steroidogenesis at a point distal to gonadotropin-receptor interaction and adenosine 3',5' cyclic monophosphate formation via openalex
- Free testosterone levels during danazol therapy via openalex
- Hormonal effects of danazol and medical oophorectomy in endometriosis via openalex
- Inhibition of steroid sulfatase activity by danazol via openalex
- In vitro effect of danazol on steroidogenesis in developing human follicles. An interim report via openalex
- Mechanism of induction of luteal phase defects by danazol via openalex
- Peripheral androgen levels in danazol-treated premenopausal women via openalex
- The influence of danazol on pituitary function and on the ovarian follicular hormone secretion in premenopausal women via openalex
- Transport of steroid hormones: interaction of 70 drugs with testosterone-binding globulin and corticosteroid-binding globulin in human plasma via openalex
- doi:10.1530/acta.0.0880190 via openalex
- doi:10.1111/j.1365-2265.1981.tb02966.x via openalex
- doi:10.1016/s0002-9378(16)32379-1 via openalex
- doi:10.1016/s0015-0282(16)43869-0 via openalex
- doi:10.3109/00016348409156998 via openalex
- doi:10.1016/0002-9378(81)90611-6 via openalex
- doi:10.3109/00365518409083783 via openalex
- doi:10.1210/jcem-52-5-868 via openalex
Cited by (8)
- A benefit-risk assessment of medical treatment for uterine leiomyomas 2002
- Plasma protein changes induced by two orally administered androgen derivatives 1996
- Glucose tolerance and insulin resistance after danazol treatment 1989
- Danazol concentrations in human ovarian follicular fluid and their relationship to simultaneous serum concentrations 1988
- Endocrine consequences of danazol treatment in menorrhagia 1986
- A comparison of the effects of danazol and gestrinone on testosterone binding to sex hormone binding globulin in vitro and in vivo 1986
- Biochemical basis for the antagonism between aminoglutethimide and danazol in the endocrine treatment of breast cancer 1986
- Danazol treatment of severely symptomatic fibrocystic breast disease and long-term follow-up--the Hjørring project 1984
Source provenance
- openalex
- last seen: 2026-05-10T11:11:16.805475+00:00
- pubmed
- last seen: 2026-10-08T21:58:20.576574+00:00
- unpaywall
- last seen: 2026-10-16T06:24:35.758740+00:00